NERV MINERVA NEUROSCIENCES INC US FDA Inspections 8-K Filing 2023 - FDA Filing for New Drug Application Minerva Neurosciences, Inc. announced that the FDA filed their New Drug Application for roluperidone for the treatment of negative symptoms in schizophrenia patients.Get access to all SEC 8-K filings of the MINERVA NEUROSCIENCES INC